The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer
Open accessAbstract
Among the cytokines linked to inflammation-associated cancer, interleukin (IL)-6 drives many of the cancer 'hallmarks' through downstream activation of the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) signaling pathway. Additionally, dysregulation of the interleukin (IL)-6-mediated JAK/STAT3 signaling pathway is closely related to the development of diverse human solid tumors including colorectal cancer (CRC). On this basis, modulation of the IL-6/JAK/STAT3 signaling pathway is currently being widely explored to develop novel therapies for CRC. The present review details the mechanisms and roles of the IL-6/JAK/STAT3 pathway in CRC, describes current therapeutic strategies, and the search for potential therapeutic approaches to treat CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980
Jess, T., Rungoe, C., & Peyrin–Biroulet, L. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.010 · Cited by 958
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Fan, Y., Mao, R., & Yang, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-2084-3 · Cited by 776
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Interleukin-6 signaling pathway in targeted therapy for cancer
Guo, Y., Xu, F., Lu, T., Duan, Z., & Zhang, Z. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.007 · Cited by 686
Candido, J., & Hagemann, T. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9847-0 · Cited by 653
Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease
CANAVAN, C., ABRAMS, K. R., & MAYBERRY, J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02854.x · Cited by 622
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Neurath, M. F., & Finotto, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.003 · Cited by 576
Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H., Semenza, G. L., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208719 · Cited by 576
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Bromberg, J., & Wang, T. C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.009 · Cited by 542
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Hedvat, M., Huszar, D., Herrmann, A., Gozgit, J. M., Schroeder, A., Sheehy, A., Buettner, R., Proia, D., Kowolik, C. M., Xin, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.015 · Cited by 526
Regulation of gene-activation pathways by PIAS proteins in the immune system
Shuai, K., & Liu, B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1667 · Cited by 447
Aoki, Y., Feldman, G. M., & Tosato, G. (2003) · Blood · doi:10.1182/blood-2002-07-2130 · Cited by 438
Xiong, H., Zhang, Z.-G., Tian, X.-Q., Sun, D.-F., Liang, Q.-C., Zhang, Y.-J., Lu, R., Chen, Y.-X., & Fang, J.-Y. (2008) · Neoplasia · doi:10.1593/neo.07971 · Cited by 426
Putoczki, T. L., Thiem, S., Loving, A., Busuttil, R. A., Wilson, N. J., Ziegler, P. K., Nguyen, P. M., Preaudet, A., Farid, R., Edwards, K. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.017 · Cited by 421
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E., & Inghirami, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205152 · Cited by 399
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
Grivennikov, S., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.020 · Cited by 368
Serum interleukin‐6 levels reflect the disease status of colorectal cancer
Chung, Y., & Chang, Y. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10269 · Cited by 353
Li, Y., de Haar, C., Chen, M., Deuring, J., Gerrits, M. M., Smits, R., Xia, B., Kuipers, E. J., & van der Woude, C. J. (2010) · Gut · doi:10.1136/gut.2009.184176 · Cited by 339
Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T., & Yoshikawa, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208788 · Cited by 339
Involvement of IL–6 in the pathogenesis of inflammatory bowel disease and colon cancer
Atreya, R., & Neurath, M. F. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:3:187 · Cited by 324
Xiong, H., Hong, J., Du, W., Lin, Y.-W., Ren, L.-L., Wang, Y.-C., Su, W.-Y., Wang, J.-L., Cui, Y., Wang, Z.-H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295964 · Cited by 307
Serum interleukin-6 levels in colorectal cancer patients—a summary of published results
Knüpfer, H., & Preiss, R. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0818-8 · Cited by 291
Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 278
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
Redell, M. S., Ruiz, M. J., Alonzo, T. A., Gerbing, R. B., & Tweardy, D. J. (2011) · Blood · doi:10.1182/blood-2010-04-280123 · Cited by 257
Review: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose-John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 251
JAKs, STATs and Src kinases in hematopoiesis
Rane, S. G., & Reddy, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205398 · Cited by 242
Alvarez, J. V., Greulich, H., Sellers, W. R., Meyerson, M., & Frank, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3757 · Cited by 240
SOCS proteins in development and disease.
Trengove, M. C., & Ward, A. C. (2013) · Europe PMC (PubMed Central) · Cited by 235
Jaks and cytokine receptors—An intimate relationship
Haan, C., Kreis, S., Margue, C., & Behrmann, I. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.013 · Cited by 229
STAT3 as a therapeutic target in head and neck cancer
Leeman, R. J., Lui, V. W. Y., & Grandis, J. R. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.3.231 · Cited by 223
Garnero, P., Thompson, E., Woodworth, T., & Smolen, J. S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25053 · Cited by 205
Brantley, E. C., Nabors, L. B., Gillespie, G. Y., Choi, Y.-H., Palmer, C. A., Harrison, K., Roarty, K., & Benveniste, E. N. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0618 · Cited by 191
Ma, J., & Cao, X. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.06.016 · Cited by 144
The role of IL-6 in the radiation response of prostate cancer
Wu, C., Chen, M., Chen, W., & Hsieh, C. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-159 · Cited by 144
Saydmohammed, M., Joseph, D., & Syed, V. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22558 · Cited by 142
Zhang, F., Li, C., Halfter, H., & Liu, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206158 · Cited by 125
Puchalski, T. A., Prabhakar, U., Jiao, Q., Berns, B., & Davis, H. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2581 · Cited by 112
Xiong, H., Du, W., Zhang, Y., Hong, J., Su, W., Tang, J. T., Wang, Y., Lu, R., & Fang, J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20777 · Cited by 111
Dambacher, J., Beigel, F., Seiderer, J., Haller, D., Göke, B., Auernhammer, C. J., & Brand, S. (2007) · Gut · doi:10.1136/gut.2006.118679 · Cited by 106
Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma
Gordziel, C., Bratsch, J., Moriggl, R., Knösel, T., & Friedrich, K. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.274 · Cited by 105
Guthrie, G. J. K., Roxburgh, C. S. D., Horgan, P. G., & McMillan, D. C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.07.003 · Cited by 105
Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo
Qin, P., Pan, H., Lou, H., Xu, Y., & Tian, L. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-69 · Cited by 98
The STAT family of proteins in cytokine signaling.
Shuai, K. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00051-0 · Cited by 95
Gao, S., Chen, C., Wang, L., Hong, L., Wu, J., Dong, P., & Yu, F. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.10.012 · Cited by 94
Hitting a complex target: an update on interleukin-6 trans-signalling
Waetzig, G. H., & Rose‐John, S. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.660307 · Cited by 93
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
Fletcher, S., Drewry, J. A., Shahani, V. M., Page, B. D. G., & Gunning, P. T. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-044 · Cited by 90
Kang, R., Tang, D., Lotze, M. T., & Zeh, H. J. (2012) · Autophagy · doi:10.4161/auto.20258 · Cited by 90
Nagaraju, G. P., Park, W., Wen, J., Mahaseth, H., Landry, J. C., Farris, A. B., Willingham, F. F., Sullivan, P. S., Proia, D. A., El‐Hariry, I. A., et al. (2013) · Angiogenesis · doi:10.1007/s10456-013-9364-7 · Cited by 90
Cytokine disbalance in common human cancers
Čulig, Z. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.010 · Cited by 90
New therapeutic strategies for treatment of inflammatory bowel disease
Atreya, R. N., & Neurath, M. F. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.7 · Cited by 84
Cai, Q., Lin, J., Wei, L., Zhang, L., Wang, L., Zhan, Y., Zeng, J., Xu, W., Shen, A., Hong, Z., et al. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13056117 · Cited by 83
Lee, J., Kim, J. C. K., Lee, S.-E., Quinley, C., Kim, H., Herdman, S., Corr, M., & Raz, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.328831 · Cited by 76
Xiong, H., Su, W., Liang, Q., Zhang, Z., Chen, H., Du, W., Chen, Y., & Fang, J. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.11 · Cited by 74
Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer
Kim, S. W., Park, K. C., Jeon, S. M., Ohn, T. B., Kim, T. I., Kim, W. H., & Cheon, J. H. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0124-x · Cited by 72
Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway
Lamy, S., Akla, N., Ouanouki, A., Lord‐Dufour, S., & Béliveau, R. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.004 · Cited by 69
Liu, D., Hu, G.-Y., Long, G., Qiu, H., Mei, Q., & Hu, G. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.18 · Cited by 62
Isomoto, H. (2009) · Digestion · doi:10.1159/000167859 · Cited by 62
Peng, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1326 · Cited by 59
Lin, W., Zheng, L., Zhuang, Q., Zhao, J., Cao, Z., Zeng, J., Lin, S., Xu, W., & Peng, J. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-144 · Cited by 58
Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer
Khong, T. L., Thairu, N., Larsen, H., Dawson, P., Kiriakidis, S., & Paleolog, E. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-518 · Cited by 56
Coordination of interleukin-6 biology by membrane bound and soluble receptors
Rose‐John, S. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0685-0_19 · Cited by 55
Zugowski, C., Lieder, F., Müller, A., Gasch, J. M., Corvinus, F. M., Moriggl, R., & Friedrich, K. (2011) · Biological Chemistry · doi:10.1515/bc.2011.038 · Cited by 55
Liu, S., Wang, K.-B., Lan, K., Lee, W. J., Pan, H. C., Wu, S., Peng, Y. C., Chen, Y. C., Shen, C. C., Cheng, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043711 · Cited by 51
Yang, X., Zhang, F., Wang, Y., Cai, M., Wang, Q., Guo, Q., Li, Z., & Hu, R. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318293c5e0 · Cited by 51
Shimazaki, J., Goto, Y., Nishida, K., Tabuchi, T., Motohashi, G., Ubukata, H., & Tabuchi, T. (2013) · Oncology · doi:10.1159/000350836 · Cited by 48
Huang, S., Chen, M., Ding, X., Zhang, X., & Zou, X. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.07.021 · Cited by 47
Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
Zhu, Z., Li, E., Liu, Y., Gao, Y. J., Sun, H., Ma, G., Wang, Z., Liu, X., Wang, Q., Qu, X., et al. (2012) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-10-228 · Cited by 41
Therapeutic Blockade of Interleukin-6 in Chronic Inflammatory Disease
Yamamoto, K., & Rose‐John, S. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.11 · Cited by 36
Chen, J.-S., Chen, Y.-H., Huang, P., Tsai, H., Chen, Y., Lin, S., & Chen, J. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-49 · Cited by 34
Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis
Shahab Uddin, M. S., Hussain, A. R., Khan, O. S., & Al-Kuraya, K. S. (2013) · Tumor Biology · doi:10.1007/s13277-013-1166-4 · Cited by 26
Ivanov, V. N., Wen, G., & Hei, T. K. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0779-1 · Cited by 25
Classical cadherins control survival through the gp130/Stat3 axis
Geletu, M., Arulanandam, R., Chevalier, S. A., Sáez, B., Larue, L., Feracci, H., & Raptis, L. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.014 · Cited by 25
Inhibition of STAT3 by RNA interference suppresses angiogenesis in colorectal carcinoma
Qian, W., Guan, W., Gao, Y., Tan, J., Qiao, Z., Huang, H., & Xia, C. L. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500143 · Cited by 22
Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice
Kuno, T., Hatano, Y., Tomita, H., Hara, A., Hirose, Y., Hirata, A., Mori, H., Terasaki, M., Masuda, S., & Tanaka, T. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs348 · Cited by 21
ECHS1 interacts with STAT3 and negatively regulates STAT3 signaling
Chang, Y., Wang, S., Wang, Y., Zhou, J., Li, W., Wang, N., Fang, D., Li, H., Li, A., Zhang, X., et al. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.02.005 · Cited by 15
Self-citation
Cited by
Paul, S., & Candelario-Jalil, E. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113518 · Cited by 748
Wu, X., Tao, P., Zhou, Q., Li, J., Yu, Z., Wang, X., Li, J., Li, C., Yan, M., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15119 · Cited by 367
Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331
Environmental immune disruptors, inflammation and cancer risk
Thompson, P. A., Khatami, M., Baglole, C. J., Sun, J., Harris, S. A., Moon, E.-Y., Al-Mulla, F., Al-Temaimi, R., Brown, D. G., Colacci, A. M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv038 · Cited by 227
Napabucasin: an update on the first-in-class cancer stemness inhibitor
Hubbard, J. M., & Grothey, A. (2017) · Drugs · doi:10.1007/s40265-017-0759-4 · Cited by 157
Metadata
- Authors
- WANG, S.-W., & SUN, Y.-M.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2014-01-15
- Volume
- 44
- Issue
- 4
- Pages
- 1032-1040
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2009062406
- Cited by
- 320
- References
- 91
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.